Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies

BACKGROUND: Gastric cancer (GC) remains a refractory cancer worldwide. Currently, exploring the differences of the immune status in GC patients with different subgroups might provide promising immunotherapeutic approaches for the treatment of GC. METHODS: In this study, a total of 598 surgically res...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Xu, Danhua, Huang, Chen, Guo, Yixian, Wang, Shuchang, Zhu, Chunchao, Xu, Jia, Zhang, Zizhen, Shen, Yanying, Zhao, Wenyi, Zhao, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554965/
https://www.ncbi.nlm.nih.gov/pubmed/31174544
http://dx.doi.org/10.1186/s12967-019-1929-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554965/
https://www.ncbi.nlm.nih.gov/pubmed/31174544
http://dx.doi.org/10.1186/s12967-019-1929-9

Ejemplares similares